Suggested Use: Take 2 tablets daily, 1 in the morning and 1 at night
Current FDA labeling does not mandate routine liver enzyme monitoring for all patients taking semaglutide, as the medication is not associated with significant hepatotoxicity risk
Never treat the numbers as interchangeable in the syringe
facilities, which are regularly inspected by the FDA
We excluded patients with bariatric surgery history and required weight measurements during baseline (90 days pre-treatment), the first year post-treatment (year 1), and the second year post-treatment (year 2), yielding 34,143 semaglutide-treated and 16,034 tirzepatide-treated patients ( Figure S1 )
We'll explore safe and effective weight management options that work for you, all from the comfort of your home